Dr. Paul Wheatley-Price chats with IMC President & CEO, Dr. Bettina Hamelin in this episode, covering off what IMC does, the role of pharma in drug development and access, opportunities for collaboration between patients, clinicians, and industry, and the drug approval process in Canada.
The role of pharma on the path to new medicines: A conversation with IMC by Lung Cancer Canada
